Related references
Note: Only part of the references are listed.Correlation between a quantitative anti-SARS-CoV-2 IgG ELISA and neutralization activity
Ramona Dolscheid-Pommerich et al.
JOURNAL OF MEDICAL VIROLOGY (2022)
Cross-protective immunity of the haemagglutinin stalk domain presented on the surface of Lactococcus lactis against divergent influenza viruses in mice
Han Lei et al.
VIRULENCE (2021)
The great escape? SARS-CoV-2 variants evading neutralizing responses
Jeremie Prevost et al.
CELL HOST & MICROBE (2021)
Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaques
Hyon-Xhi Tan et al.
NATURE COMMUNICATIONS (2021)
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
David S. Khoury et al.
NATURE MEDICINE (2021)
Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel
Yinon M. Bar-On et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia
Qun Li et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
Michael Letko et al.
NATURE MICROBIOLOGY (2020)
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
Alba Grifoni et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Oral delivery of maize-produced porcine epidemic diarrhea virus spike protein elicits neutralizing antibodies in pigs
Erin Egelkrout et al.
PLANT CELL TISSUE AND ORGAN CULTURE (2020)
Antibody responses to SARS-CoV-2 in patients with COVID-19
Quan-Xin Long et al.
NATURE MEDICINE (2020)
Emergence of Drift Variants That May Affect COVID-19 Vaccine Development and Antibody Treatment
Takahiko Koyama et al.
PATHOGENS (2020)
A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition
M. Eugenia Dieterle et al.
CELL HOST & MICROBE (2020)
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Takuya Sekine et al.
CELL (2020)
Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity
Carolyn Rydyznski Moderbacher et al.
CELL (2020)
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
Nina Le Bert et al.
NATURE (2020)
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Quan-Xin Long et al.
NATURE MEDICINE (2020)
Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate
Amin Addetia et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2020)
Broad and strong memory CD4+and CD8+T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
Yanchun Peng et al.
NATURE IMMUNOLOGY (2020)
Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancement
Wen-Hsiang Chen et al.
VACCINE (2020)
Oral Vaccination with Replication-Competent Adenovirus in Mice Reveals Dissemination of the Viral Vaccine beyond the Gastrointestinal Tract
Emeline Goffin et al.
JOURNAL OF VIROLOGY (2019)
Immunization with recombinant fusion of LTB and linear epitope (40-62) of epsilon toxin elicits protective immune response against the epsilon toxin of Clostridium perfringens type D
Himani Kaushik et al.
AMB EXPRESS (2019)
Origin and evolution of pathogenic coronaviruses
Jie Cui et al.
NATURE REVIEWS MICROBIOLOGY (2019)
Comparative immunogenicity of preparations of yeast-derived dengue oral vaccine candidate
Jyotiranjan Bal et al.
MICROBIAL CELL FACTORIES (2018)
Expression of an immunogenic LTB-based chimeric protein targeting Zaire ebolavirus epitopes from GP1 in plant cells
Regina Rios-Huerta et al.
PLANT CELL REPORTS (2017)
Polio vaccination: past, present and future
Ananda S. Bandyopadhyay et al.
FUTURE MICROBIOLOGY (2015)
Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies
Shujing Wang et al.
PROTEIN & CELL (2015)
Current advancements and potential strategies in the development of MERS-CoV vaccines
Naru Zhang et al.
EXPERT REVIEW OF VACCINES (2014)
Immune responses of a chimaeric protein vaccine containing Mycoplasma hyopneumoniae antigens and LTB against experimental M-hyopneumoniae infection in pigs
Silvana B. Marchioro et al.
VACCINE (2014)
Production and Evaluation of a Recombinant Chimeric Vaccine against Clostridium botulinum Neurotoxin Types C and D
Luciana A. F. Gil et al.
PLOS ONE (2013)
Construction and immunogenicity evaluation of an epitope-based antigen against swine influenza A virus using Escherichia coli heat-labile toxin B subunit as a carrier-adjuvant
Zhi Sun et al.
VETERINARY MICROBIOLOGY (2013)
Transgenic tobacco expressed HPV16-L1 and LT-B combined immunization induces strong mucosal and systemic immune responses in mice
Liu Hongli et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Dendritic Cell Targeted Chitosan Nanoparticles for Nasal DNA Immunization against SARS CoV Nucleocapsid Protein
Dharmendra Raghuwanshi et al.
MOLECULAR PHARMACEUTICS (2012)
Functional Pentameric Formation via Coexpression of the Escherichia coli Heat-Labile Enterotoxin B Subunit and Its Fusion Protein Subunit with a Neutralizing Epitope of ApxIIA Exotoxin Improves the Mucosal Immunogenicity and Protection against Challenge by Actinobacillus pleuropneumoniae
Jung-Mi Kim et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Plastid expression of a double-pentameric vaccine candidate containing human papillomavirus-16 L1 antigen fused with LTB as adjuvant: transplastomic plants show pleiotropic phenotypes
Mohammad T. Waheed et al.
PLANT BIOTECHNOLOGY JOURNAL (2011)
Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles
Olga Borges et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2008)
The SARS-CoV nucleocapsid protein: A protein with multifarious activities
Milan Surjit et al.
INFECTION GENETICS AND EVOLUTION (2008)
A prime-boost vaccination protocol optimizes immune responses against the nucleocapsid protein of the SARS coronavirus
Kai Schulze et al.
VACCINE (2008)
B subunit of E-coli enterotoxin as adjuvant and carrier in oral and skin vaccination
E. Fingerut et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2006)
A recombinant chimera composed of R1 repeat region of Mycoplasma hyopneumoniae P97 adhesin with Escherichia coli heat-labile enterotoxin B subunit elicits immune response in mice
Fabricio Rochedo Conceicao et al.
VACCINE (2006)
Diphtheria toxoid loaded poly-(ε-caprolactone) nanoparticles as mucosal vaccine delivery systems
J Singh et al.
METHODS (2006)
Vaccine and adjuvant activity of recombinant subunit B of E-coli enterotoxin produced in yeast
E Fingerut et al.
VACCINE (2005)
Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres
KS Jaganathan et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Immunogenicity of recombinant LT-B delivered orally to humans in transgenic corn
CO Tacket et al.
VACCINE (2004)
Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection
R Weltzin et al.
INFECTION AND IMMUNITY (2000)
Share Paper
